GLP1R and type 2 diabetes mellitus: Therefore, gut microbiota modulators can modulate BA metabolism and improve T2DM symptoms by altering the composition of the gut microbiota, which is associated with the inhibition of FXR‐FGF15 signalling and promotion of TGR5‐GLP‐1 signalling.